Keratinocyte carcinoma (KC) is the most common malignant disease in solid organ transplant recipients, but we know little about its association with overall (generic) health-related quality of life (HRQoL) and KC-specific HRQoL in solid organ transplant recipients.1,2 Although previous research showed that sun-protective behavior increases after KC treatment,3 this topic is not addressed by KC-specific HRQoL questionnaires.4 The recently developed Basal and Squamous Cell Carcinoma Quality of Life (BaSQoL) questionnaire does assess the association of behavior changes with HRQoL.5 In this study, we compared generic HRQoL between solid organ transplant recipients with and without KC and explored variables associated with KC-specific HRQoL in solid organ transplant recipients using the BaSQoL.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Frie M, Annema C, Knijff ESX, et al. Health-Related Quality of Life in Solid Organ Transplant Recipients With vs Without Keratinocyte Carcinoma. JAMA Dermatol. Published online January 30, 2020. doi:10.1001/jamadermatol.2019.4541
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: